What's New in the Pathophysiology of Sickle Cell Disease?

Publisher： Karger

E-ISSN： 1423-0151|22|4|311-312

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.22, Iss.4, 2013-04, pp. : 311-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pulmonary Hypertension Associated with Sickle Cell Disease: Pathophysiology and Rationale for Treatment

By Benza Raymond

Lung, Vol. 186, Iss. 4, 2008-08 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease: The Rationale for Arginine Therapy

By Morris Claudia R.

Treatments in Respiratory Medicine, Vol. 5, Iss. 1, 2006-01 ,pp. : 31-45

Adis International

Access to resources Recommend Favorite

Hypercoagulability in sickle cell disease: a curious paradox

By Ataga K.I. Orringer E.P.

The American Journal of Medicine, Vol. 115, Iss. 9, 2003-12 ,pp. : 721-728

Elsevier

Access to resources Recommend Favorite

Cervical Artery Stenoses in Sickle Cell Disease

European Neurology, Vol. 58, Iss. 2, 2007-06 ,pp. : 120-121

Karger

Access to resources Recommend Favorite

Transcranial Doppler in Adult Patients with Sickle Cell Disease

Cerebrovascular Diseases, Vol. 21, Iss. 1-2, 2006-01 ,pp. : 38-41

Karger

Access to resources Recommend Favorite